SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Approves GE Healthcare’s SenoBright Spectral Mammography Device

October 17, 2011 | 
1 min read
The U.S. Food and Drug Administration has cleared GE Healthcare’s SenoBright contrast enhanced spectral mammography unit.
FDA Approvals Europe
MORE ON THIS TOPIC
3D Yellow triangle warning sign symbol on yellow background. Emergency alert, and caution. Illustration with copy space
Drug Development
Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains hold
October 8, 2026
 · 
2 min read
 · 
Gabrielle Masson
Insights
Beyond equity: Why venture debt is reshaping European biotech
October 8, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Vintage white spiral clock dial with roman numerals. Concept of Infinite time, deadline, scheduling, time and space, past, present and future.
Manufacturing
FDA extends review of Novo’s hemophilia A drug, citing manufacturing issues
October 6, 2026
 · 
2 min read
 · 
Gabrielle Masson
Vector, flat illustration
Opinion
FDA must ensure American patients can access new and experimental drugs
October 5, 2026
 · 
7 min read
 · 
Houman David Hemmati